| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 10 4468-4477, Copyright © 1994 by American Association of Immunologists
ARTICLES |
T Monji, AL McCormack, JR Yates 3rd and D Pious
Department of Microbiology, University of Washington, Seattle 98195.
Class II presentation mutants have mutations in the HLA-DMA or B genes and are defective in the presentation of whole exogenous Ags restricted by HLA-DR, -DQ, and -DP. The functional defect in Ag presentation is accompanied by an altered conformation of cell surface class II molecules and instability of extracted class II dimers in SDS-PAGE; the latter can be corrected by incubation of mutant cells in an acidic pH in the presence of cognate peptide. Here we investigated the basis for correction of class II dimer instability by acid/cognate peptide treatment and the extent to which this treatment corrects the class II conformational defect in DMB mutants. We found that an acidic pH generates peptide binding sites in class II molecules of DMB mutants by eluting invariant chain (li)-derived peptides from them. Cognate peptides can then bind to the empty binding sites of class II molecules in a pH-independent manner, which results in stabilization of class II dimers. Acid/peptide treatment also restores the DR polymorphic epitope recognized by mAb 7.3.19.1 but not the DR polymorphic epitope recognized by mAb 16.23; low pH gradually destroys the 16.23 epitope in nonmutant cells. Mutant 10.24.6, which has a mutation in the DRA coding region creating an extra glycosylation site, also has unstable DR dimers whose stability is restored by acid/peptide treatment. These results suggest that the primary phenotypic defect in both the DMB and 10.24.6 mutants is the abundance of li peptides and lack of cognate peptides bound to class II molecules.
This article has been cited by other articles:
|
|
 |
|
  J. D. Lich, J. A. Jayne, D. Zhou, J. F. Elliott, and J. S. Blum Editing of an Immunodominant Epitope of Glutamate Decarboxylase by HLA-DM J. Immunol., July 15, 2003; 171(2): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok {beta}57-Asp Plays an Essential Role in the Unique SDS Stability of HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Allele Associated with Protection from Insulin-Dependent Diabetes Mellitus J. Immunol., September 15, 2000; 165(6): 3232 - 3238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok Exceptional Stability of the HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Molecule Associated with Protection from Insulin-Dependent Diabetes Mellitus J. Immunol., December 1, 1998; 161(11): 6439 - 6445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Guerra, R. Busch, R. C. Doebele, W. Liu, T. Sawada, W. W. Kwok, M.-d. Y. Chang, and E. D. Mellins Novel Glycosylation of HLA-DR{alpha} Disrupts Antigen Presentation Without Altering Endosomal Localization J. Immunol., May 1, 1998; 160(9): 4289 - 4297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Busch, R. C. Doebele, E. von Scheven, J. Fahrni, and E. D. Mellins Aberrant Intermolecular Disulfide Bonding in a Mutant HLA-DM Molecule: Implications for Assembly, Maturation, and Function J. Immunol., January 15, 1998; 160(2): 734 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Fling, J. Rak, K. A. Muczynski, B. Arp, and D. Pious Novel Mutants Define Genes Required for the Expression of Human Histocompatibility Leukocyte Antigen DM: Evidence for Loci on Human Chromosome 6p J. Exp. Med., November 3, 1997; 186(9): 1469 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Faubert, A. Samaan, and J. Thibodeau Functional Analysis of Tryptophans alpha 62 and beta 120 on HLA-DM J. Biol. Chem., January 18, 2002; 277(4): 2750 - 2755. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
